SILO PHARMA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1 USD | +3.08% |
|
+2.04% | -30.56% |
| 22/06 | Certain Common Stock of Silo Pharma, Inc. are subject to a Lock-Up Agreement Ending on 22-JUN-2024. | CI |
| 11/06 | Silo Pharma, Inc. announced that it has received $2.077409 million in funding | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 35.77L | - | - | - | - | - | |
| 9.48TCr | ||||||
| 3.76TCr | ||||||
| 3.33TCr | ||||||
| 2.79TCr | ||||||
| 1.59TCr |
- Stock Market
- Equities
- SILO Stock
- Charts Silo Pharma, Inc.
- Sector Chart
